Kathleen Laporte, Director at Bolt Biotherapeutics, Inc. (BOLT), bought 1,200 shares at $20.00 ($24K) on 2021-02-09, disclosed to the SEC on 2021-02-09.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| AFFY | SELL | 2012-12-18 | $114K | — | Filing → |
| AFFY | SELL | 2011-07-05 | $639K | — | Filing → |
| AFFY | SELL | 2011-06-30 | $5.3M | — | Filing → |